Psychiatry & Neurology, Sleep Medicine · Downey, CA
NPI
1639130693
Since 2006
Specialty
Psychiatry & Neurology, Sleep Medicine
Code 2084S0012X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
11480 Brookshire Avenue, # 108
Downey, CA, 90241
Phone (562) 904-1101
Groups this clinician bills Medicare through
Medicare paid, 2024
$124K
1,760 services
Medicare patients, 2024
574
Average age 74
Drug cost, 2024
$1.9M
6,412 prescriptions
Company payments, 2025
$83K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark Buchfuhrer was code 99213 (office e&m - established), 477 times for 339 patients. In total Mark Buchfuhrer billed 1,760 services in 16 codes, and Medicare paid $124K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 477 | 339 | $66.76 | $32K |
| 99214 Office E&M - Established | Office | 330 | 230 | $94.35 | $31K |
| 94729 Pulmonary Function Testing | Office | 173 | 172 | $49.40 | $8,547 |
| 94060 Pulmonary Function Testing | Office | 173 | 172 | $32.69 | $5,656 |
| 94727 Pulmonary Function Testing | Office | 173 | 172 | $38.05 | $6,583 |
| 94618 Pulmonary Function Testing | Office | 141 | 140 | $27.97 | $3,944 |
| 99205 Office E&M - New | Office | 116 | 116 | $176.36 | $20K |
| 99215 Office E&M - Established | Office | 71 | 69 | $130.86 | $9,291 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 41 | 29 | $27.06 | $1,110 |
| 95811 Sleep Study | Office | 21 | 21 | $84.84 | $1,782 |
| 95810 Sleep Study | Office | 16 | 16 | $84.70 | $1,355 |
| 99204 Office E&M - New | Office | 15 | 15 | $143.79 | $2,157 |
By year: 2022 $116K for 1,519 services; 2023 $122K for 1,734 services; 2024 $124K for 1,760 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark Buchfuhrer prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 811 prescriptions and refills. In total Mark Buchfuhrer wrote 6,412 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 811 | 961 | 173 | $585K |
| Methadone Hcl Generic | 475 | 482 | 89 | $7,743 |
| Fluticasone Propionate Generic | 323 | 569 | 127 | $4,042 |
| Gabapentin Generic | 274 | 435 | 61 | $3,793 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 242 | 252 | 70 | $26K |
| Oxycodone Hcl Generic | 234 | 236 | 37 | $3,608 |
| Atorvastatin Calcium Generic | 223 | 616 | 66 | $2,203 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 205 | 278 | 77 | $526 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 187 | 226 | 68 | $5,743 |
| Breo Ellipta Fluticasone/Vilanterol | 171 | 223 | 32 | $85K |
| Pregabalin Generic | 157 | 183 | 21 | $3,221 |
| Zolpidem Tartrate Generic | 154 | 167 | 37 | $2,237 |
| Montelukast Sodium Generic | 126 | 294 | 32 | $1,103 |
| Lisinopril Generic | 121 | 324 | 32 | $904 |
| Belbuca Buprenorphine Hcl | 110 | 124 | 16 | $105K |
Brand drugs: - claims; generic drugs: 4,532 claims; opioid claims: 1,157.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark Buchfuhrer $83K ($23K in general payments such as food, travel and fees and $60K for research) from 20 companies. The largest payer was Noctrix Health, Inc. with $81K.
| Company | Payments | Amount |
|---|---|---|
| Noctrix Health, Inc. | 23 | $81K |
| Jazz Pharmaceuticals Inc. JAZZ | 9 | $453 |
| GlaxoSmithKline, LLC. GSK | 22 | $397 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $365 |
| Harmony Biosciences LLC HRMY | 9 | $320 |
| Avadel CNS Pharmaceuticals, LLC | 8 | $188 |
| Genzyme Corporation SNY | 7 | $172 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $165 |
| Collegium Pharmaceutical, Inc. COLL | 8 | $150 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $98.34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.